Purpose
The aim of this investigation was to evaluate prognostic factors influencing the short-term prognosis of occult choroidal
neovascularization (CNV).
Methods
A consecutive series of 107 untreated occult CNV in 101 patients were evaluated in terms of the effect of their initial lesion
characteristics, as determined with fluorescein angiography (FA), indocyanine green angiography (ICG-A) and optical coherence
tomography (OCT), on the change in distance acuity, lesion size and retinal thickness over 1–3 months. Descriptive statistics,
the Pearson Correlation Coefficient and a multiple linear regression analysis were applied to treat the data.
Results
A total of 107 eyes (101 patients) were examined. The study cohort consisted of 35 males and 66 females, with a mean age of
77.6 years. During the 3-month study period the mean distance acuity decreased from 67.0 to 63.2 letters; the mean size of
the lesion increased from 16.1 to 18.4 mm2; the mean maximum retinal thickness increased from 374.5 to 387.5 μm. Of the lesions, 59.8% included pigment epithelial detachments
(serous or fibrovascular) and 29.9% retinal angiomatous proliferation. A better distance acuity at both visits for the entire
study population correlated significantly with smaller lesions, as determined by FA and ICG-A (p < 0.0001), and a lower maximum retinal thickness, as determined by the OCT (p < 0.0001).
Conclusions
A small and statistically insignificant change in distance acuity, lesion size and retinal thickness occurred over the 3 months
of the study period. This reduced the ability of the study to examine the effect of baseline findings on outcome. Only two
factors – the presence of a RAP lesion or the presence of CNV in the other eye – significantly and adversely affected the
distance visual acuity at follow-up.
Keywords Age-related macular degeneration - Choroidal neovascularization - Retinal angiomatous proliferation - Optical coherence tomography
None of the authors has a financial interest related to the manuscript.
The author(s) guarantee(s) that the manuscript will not be published elsewhere in any language without the consent of the
copyright holders, that the rights of third parties will not be violated, and that the publisher will not be held legally
responsible should there be any claims for compensation.